MILLENNIUM MANAGEMENT LLC - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 48 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q2 2019$111,000
-76.6%
95,262
+37.0%
0.00%
-100.0%
Q3 2018$475,000
+9.2%
69,519
+276.4%
0.00%0.0%
Q2 2018$435,000
-88.0%
18,469
-86.0%
0.00%
-80.0%
Q1 2018$3,616,000–132,083–0.01%–
 Download
Other shareholders

There were no reported owners of INNOVATE BIOPHARMACEUTICLS I in Q3 2018.

NameSharesValueWeighting ↓
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders